Drugs / EGF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04995354 | Jun → Dec 2022 | chemotherapy-induced oral mucositis | Cairo University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EGF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04995354 ↗ |
| Modality | Protein / enzyme biologic | “Self Healing Gel as a Vehicle for Recombinant Human Epidermal Growth Factor in Treatment of Oral Mucositis Following Cancer Therapy” NCT04995354 ↗ |
| Route | Topical | “when the patient applies the gel thrice daily” NCT04995354 ↗ |